Semaglutide is a synthetic peptide analogue extensively studied for its role in incretin-mediated metabolic pathways. It functions as a GLP-1 (glucagon-like peptide-1) receptor agonist, a class of compounds investigated for their effects on:
Glucose-dependent insulin secretion
Regulation of hepatic glucose production
Delayed gastric emptying
Appetite-related signalling pathways
This product is supplied as a 10 mg lyophilised peptide vial, intended for informed purchasers who have independently researched the compound and have consulted appropriate healthcare professionals.
Clinical Trial Evidence (Phase 3)
Semaglutide has been evaluated in multiple large-scale Phase 3 clinical trial programmes.
In Phase 3 trials conducted under controlled conditions, semaglutide demonstrated clinically meaningful and sustained reductions in body weight, with participants in certain studies achieving average weight reductions of approximately 14–15% over 68 weeks, depending on study design and protocol.
Phase 3 programmes also assessed long-term safety, tolerability, and metabolic outcomes, and these data formed the basis for regulatory review and approval in various jurisdictions.
Results observed in clinical trials reflect controlled research environments and do not guarantee similar outcomes in other settings.
How Semaglutide Compares
Semaglutide is often discussed alongside newer incretin-based peptides:
Semaglutide acts as a single-pathway GLP-1 receptor agonist
Tirzepatide targets both GLP-1 and GIP receptors (dual agonist)
Retatrutide additionally engages the glucagon receptor (triple agonist)
Semaglutide represents an established GLP-1–based compound within this broader class.
Important Information
This product is supplied in a lyophilised peptide format
Consultation with a licensed healthcare provider is essential prior to any consideration of use
Results observed in clinical trials may not reflect real-world outcomes
This product is supplied strictly on an informed purchaser basis. By purchasing, you acknowledge that:
You have independently researched this product and its investigational status
You have consulted, or will consult, a qualified healthcare professional
The seller provides no medical advice, treatment claims, or dosing guidance
The onus of lawful, safe, and appropriate use rests entirely with the purchaser
